Literature DB >> 29561353

Thirty-Day Readmissions After Upper and Lower Gastrointestinal Hemorrhage: A National Perspective in the United States.

Smit D Patel1, Rupak Desai2, Upenkumar Patel3, Sandeep Singh4, Zinal Patel5, Neel Patel6, Allan Zhang1, Amruta H Panwala1, Vinshi N Khan7, Gagandeep Singh8, Nihar Shah9.   

Abstract

BACKGROUND: Upper gastrointestinal hemorrhage (UGIH) and lower gastrointestinal hemorrhage (LGIH) are 2 of the most common reasons for hospital admissions across the United States. The 30-day readmission after index admission poses a major burden on the health care infrastructure, and thus, it is important to assess the causes of 30-day readmission for patients with UGIH and LGIH.
METHODS: The study cohort was derived from the 2013 National Readmission Database. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Volume 3 diagnosis codes were utilized to identify UGIH and LGIH patients from this data set. Patients who were readmitted to the hospital within 30 days within the same calendar year were further analyzed. Categorical variables and continuous variables were assessed by the χ test and the student t test, respectively. The independent predictors of unplanned 30-day readmissions were recognized by multivariate logistic regression, adjusting for stratified cluster design of National Readmission Database. SAS 9.4 (SAS Institute Inc., Cary, NC) was used for data analysis.
RESULTS: The number of index admissions identified from the National Readmission Data 2013 were 82,290 for UGIH and 133,114 for LGIH. All-cause 30-day readmission rate for UGIH versus LGIH was 14.6% (readmitted N=12,046; 56.64% age 65 y and above) versus 14.4% (readmitted N=19,128; 70.21% age 65 y and above and 49.61% men). Gastrointestinal causes were most common (33.9% vs. 39.6%), followed by cardiac (13.3% vs. 15.3%), infectious (10.4% vs. 9.1%), and respiratory causes (7.8% vs. 7.1%) for 30-day readmission for UGIH and LGIH. Significant predictors of increased 30-day readmission (odds ratio, 95% confidence interval, P-value) included metastatic disease (2.15, 1.75-2.64, P<0.001), discharge against medical advice (1.85, 1.55-2.22, P<0.001), and length of stay >3 days (1.50, 1.38-1.63, P<0.001). Predictors for 30-day readmission for LGIH included metastatic disease (1.75, 1.48-2.06, P<0.001), liver disease (1.59, 1.49-1.71, P<0.001), and drug abuse (1.38, 1.21-1.58, P<0.001).
CONCLUSIONS: Most common reason for UGIH and LGIH readmission was related to gastrointestinal disease, followed by cardiac, infectious, and respiratory etiologies. By addressing these etiologies for readmission, it may be possible to reduce adverse outcomes.

Entities:  

Year:  2019        PMID: 29561353     DOI: 10.1097/MCG.0000000000001020

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  4 in total

1.  Early Colonoscopy Does Not Affect 30-Day Readmission After Lower GI Bleeding: Insights from a Nationwide Analysis.

Authors:  Sachit Sharma; Deema Sallout; Ashu Acharya; Douglas G Adler
Journal:  Dig Dis Sci       Date:  2021-09-14       Impact factor: 3.487

2.  Predictors of blood transfusion and in-hospital outcomes in patients with gastric antral vascular ectasia (GAVE): a nationwide population-based analysis.

Authors:  Upenkumar Patel; Rupak Desai; Jiten Desai; Nanush Damarlapally; Dipen Zalavadia; Mohamad Yousef; Roxana Coman; Pardeep Bansal; Hemant Goyal
Journal:  Ann Transl Med       Date:  2019-02

3.  Primary Causes of Hospitalizations and Procedures, Predictors of In-hospital Mortality, and Trends in Cardiovascular and Cerebrovascular Events Among Recreational Marijuana Users: A Five-year Nationwide Inpatient Assessment in the United States.

Authors:  Rupak Desai; Sofia Shamim; Krupa Patel; Ashish Sadolikar; Vikram Preet Kaur; Siddhi Bhivandkar; Smit Patel; Sejal Savani; Zeeshan Mansuri; Zabeen Mahuwala
Journal:  Cureus       Date:  2018-08-23

4.  A Protocol for a Systematic Review and Meta-Analysis of Hospital Readmissions Following Acute Upper Gastrointestinal Bleeding.

Authors:  Sandeep Kaur; Cody L Dunne; Lauren Bresee
Journal:  Cureus       Date:  2021-11-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.